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The concept of mobile Health (mHealth) refers to the use of diagnostic devices which can provide information from a remote distance, via internet pathways, that can influence the therapeutic management in a variety of disorders.
Several electronic tools have been tested and proven useful in simplifying the cardiovascular management of patients, more specifically mobile applications that are compatible with the Android system, which have led to a 25.5% improvement in quality of primary medical care, patient prognosis, as well as better efficacy of measures for secondary cardiovascular prevention. 1 Such applications include remote monitoring devices for evaluation of cardiac rhythms via iECG, which uses a smartphone (iPhone) with incorporated monitoring electrodes for telemetric cardiac rhythm recordings. Furthermore, such devices include blood pressure measurement tools, which have the configuration of a smartwatch or bracelet that uses the applanation tonometry technique. 2 For heart failure patients, mHealth applications include a remote monitoring device that records the filling pressures within the left ventricle and the pulmonary artery, which is based on a micro-electromechanical system that is implanted at the level of the pulmonary artery. Electronic devices applied in cardiac care can be used in every phase of patient management, both in acute and long-term care settings, including mobile health in cardiac arrest, rhythm disturbances, acute myocardial infarction, or heart failure. Out-of-hospital cardiac arrest (OHCA) is related to high mortality rates, and timely initiation of correct resuscitation maneuvers could be life-saving. 6 Mobile life-saver is a smartphone application that can identify and alert volunteers that have been trained in cardio-pulmonary resuscitation, and which led to a faster time from OHCA to chest compression. 7 In acute myocardial infarction, it is well known that a decreased time from onset of symptoms to interventional treatment is associated with a significant improvement in survival, as well as short-and long-term complications. 8 However, although in case of activation of a STEMI network by a non-cardiologist specialist reduces times to treatment, it may also increase the rate of false positive activation of such networks. 9 The use of transtelephonic ECG interpretation by a remote cardiology specialist has been shown to reduce STEMI network times, to improve pre-hospital pharmacological treatment and time to reperfusion therapies, as well as in-hospital mortality for STEMI, while decreasing the rate of false activation of such networks.
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On the other hand, currently there is no mHealth de- • the use of complex apps that integrate a multitude of remote data (ECG, echocardiography, hemodynamic monitoring devices) in one mHealth device applied in cardiology;
• remote hemodynamic monitoring, cardiac rhythm monitoring, and remote interrogation of implantable cardiovascular devices such as intracardiac defibrillator and pacemakers.
In Romania, a country in which cardiovascular disease in the main cause of mortality and morbidity, the number of medical specialists divided to the total population is one 
